DANIELLE ABEL: Open Payments
NPI 1255751731 · SEWICKLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 99 payments from 15 companies in 2025. Trend: 2023 $2,080 · 2024 $2,626 · 2025 $1,727
Food & beverage: $1,628Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 36 | $594 |
| GENZYME CORPORATION | 11 | $187 |
| UCB, Inc. | 8 | $145 |
| ABBVIE INC. | 11 | $135 |
| E.R. Squibb & Sons, L.L.C. | 6 | $112 |
| Arcutis Biotherapeutics, Inc. | 4 | $99 |
| Amgen Inc. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| PFIZER INC. | 4 | $84 |
| Lilly USA, LLC | 3 | $69 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, AXERT, Sotyktu, Zoryve, OTEZLA.
Industry payments across PA — which companies pay providers there.
